لقاح_فيروس_نقص_المناعة_البشرية
اقتصاديات تطوير اللقاحات
تثبيط عملية التمثيل الغذائي للخلايا المصابة تثبيط تبادل الطاقة للخلايا المصابة Healy, Melissa (25 April 2013). "Government shuts down AIDS vaccine trial - latimes.com". Los Angeles Times. Los Angeles: Tribune Co. ISSN 0458-3035. Retrieved 25 April 2013. Joint United Nations Programme on HIV/AIDS (UNAIDS) (December 2005). "AIDS epidemic update" (PDF). World Health Organization. Retrieved 2014-04-22. UNAIDS (2004) Report on the global AIDS epidemic, July 2004 Shilts, Randy (1987). And the Band Played On: Politics, People, and the AIDS Epidemic. (2007 ed.). St. Martin's Press. ISBN 0-312-24135-6. p. 451 Watkins DI (Mar 2008). "Basic HIV Vaccine Development" (PDF). Top HIV Med. 16 (1): 7–8. ISSN 1542-8826. PMID 18441377. A. S. Fauci, 1996, An HIV vaccine: breaking the paradigms, Proc. Am. Assoc. Phys. 108:6. Kim D.; Elizaga M.; Duerr A. (March 2007). "HIV vaccine efficacy trials: towards the future of HIV prevention". Infect. Dis. Clin. North Am. 21 (1): 201–17, x. doi:10.1016/j.idc.2007.01.006. ISSN 0891-5520. PMID 17502236. Watkins DI (March 2008). "The hope for an HIV vaccine based on induction of CD8+ T lymphocytes - A Review". Mem. Inst. Oswaldo Cruz. 103 (2): 119–29. doi:10.1590/S0074-02762008000200001. ISSN 0074-0276. PMC 2997999Freely accessible. PMID 18425263. Létourneau S., Im EJ, Mashishi T, et al. (Oct 2007). Nixon D, ed. "Design and Pre-Clinical Evaluation of a Universal HIV-1 Vaccine". PLoS ONE. 2 (10): e984. doi:10.1371/journal.pone.0000984. PMC 1991584Freely accessible. PMID 17912361. Poignard P, Sabbe R., Picchio G. R., et al. (April 1999). "Neutralizing antibodies have limited effects on the control of established HIV-1 infection in vivo". Immunity. 10 (4): 431–8. doi:10.1016/S1074-7613(00)80043-6. ISSN 1074-7613. PMID 10229186. Berman PW, Gregory T. J., Riddle L., et al. (June 1990). "Protection of chimpanzees from infection by HIV-1 after vaccination with recombinant glycoprotein gp120 but not gp160". Nature. 345 (6276): 622–5. doi:10.1038/345622a0. ISSN 0028-0836. PMID 2190095. Connor RI, Korber B. T., Graham B. S., et al. (February 1998). "Immunological and Virological Analyses of Persons Infected by Human Immunodeficiency Virus Type 1 while Participating in Trials of Recombinant gp120 Subunit Vaccines". Journal of Virology. 72 (2): 1552–76. ISSN 0022-538X. PMC 124637Freely accessible. PMID 9445059. Morgan C., Marthas M., Miller C., et al. (August 2008). "The Use of Nonhuman Primate Models in HIV Vaccine Development". PLoS Med. 5 (8): e173. doi:10.1371/journal.pmed.0050173. ISSN 1549-1277. PMC 2504486Freely accessible. PMID 18700814. Marques, R.; Williams, A.; Eksmond, U.; Wullaert, A.; Killeen, N.; Pasparakis, M.; Kioussis, D.; Kassiotis, G. (2009). "Generalized immune activation as a direct result of activated CD4+ T cell killing". Journal of Biology. 8 (10): 93. doi:10.1186/jbiol194. PMC 2790834Freely accessible. PMID 19943952. Vrisekoop, N.; Mandl, J. N.; Germain, R. N. (2009). "Life and death as a T lymphocyte: from immune protection to HIV pathogenesis". Journal of Biology. 8 (10): 91. doi:10.1186/jbiol198. PMC 2790836Freely accessible. PMID 19951397. Pavot, V; Rochereau, N; Lawrence, P; Girard, MP; Genin, C; Verrier, B; Paul, S (31 July 2014). "Recent progress in HIV vaccines inducing mucosal immune responses.". AIDS (London, England). 28 (12): 1701–18. doi:10.1097/qad.0000000000000308. PMID 25009956. "New Vaccine Could Turn HIV Into Minor Infection". Fox News. 2011-09-29. Retrieved 29 September 2011. "STEP Study Locations". Retrieved 2008-11-04. Efficacy Results from the STEP Study (Merck V520 Protocol 023/HVTN 502): A Phase II Test-of-Concept Trial of the MRKAd5 HIV-1 Gag/Pol/Nef Trivalent Vaccine Sekaly, R. P. (2008). The failed HIV Merck vaccine study: a step back or a launching point for future vaccine development? Journal of Cell Biology, 205, (1), 7-12 Timberg, Craig (2007-10-25). "AIDS vaccine may have raised risk of infection". The Washington Post. Retrieved 2007-11-12.